Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic for Postoperative Pain in RARP
NCT05685342Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetaminophen + ibuprofen in postoperative pain, sponsored by Seoul National University Hospital. Primary endpoint: Total fentanyl consumption during 24 hours. Started Feb 2023; status: completed.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05685342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05685342.